SpringerLink
Log in

The Role of the HL-10 Peptide in Regulating the Expression of Apoptosis-Related Genes in the HeLa Cancer Cell Line

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Anticancer peptides are among the most important bioactive peptides found in animal sources. The modulation of the molecular process of apoptosis via the genes involved in the signaling pathway is now being studied for cancer treatment. In this study, the anticancer properties of peptide HL-10 extracted from scorpion venom by regulating the apoptosis signaling pathway were investigated. In the present study, the anticancer activity of the HL-10 peptide against the HeLa cancer cell line was assessed using the cytotoxicity assay. The real-time PCR method was used to analyse the expression levels of Bax, p53, caspase-3, PTEN, and Akt genes. The cytotoxicity assay demonstrated that the IC50 value of the HL-10 peptide was 40 μM. The results also showed that the treatment of Hela cells with HL-10 led to an increase in the expression of Bax, p53, caspase-3, and PTEN genes, while it resulted in a significant decrease in the expression level of the Akt gene in a dose-dependent manner (p.05). The flow cytometry analysis also revealed a high number of cells in the secondary apoptotic stage. According to changes in the expression of genes implicated in the apoptosis pathway, the HL-10 peptide appears to play a role in the activation of the intrinsic apoptosis pathway. However, additional research in molecular dimensions and clinical studies is needed. It is suggested to confirm the effectiveness of HL-10 peptide in cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. P. Anand, A. B. Kunnumakkara, C. Sundaram, et al., Pharma. Res., 25(9), 2097 – 2016 (2008).

    Article  CAS  Google Scholar 

  2. R. Rahbari, T. Sheahan, V. Modes, et al., BioTechniques, 46(4), 277 – 284 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. A. Capes, G. Theodosopoulos, I. Atkin, et al., Int. J. Cancer, 127(1), 1 – 8 (2010).

    Article  Google Scholar 

  4. R. J. Youle, and A. Strasser, Nat. Rev. Mol. Cell. Biol., 9(1), 47 – 59 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. M. Flórez, H. B. Fêo, G. Da Silva, et al., Vet. Comp. Oncol., 15, 793 – 807 (2017).

    Article  PubMed  Google Scholar 

  6. V. T. DeVita, and S. A. Rosenberg, N. Engl. J. Med., 366(23), 2207 – 2214 (2012).

    CAS  Google Scholar 

  7. M. Ejtehadifar, R. Halabian, A. A. I. Fooladi, et al., Microb. Pathog., 113, 438 – 444 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. F. Schweizer, Eur. J. Pharmacol., 625(1 – 3), 190 – 194 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Z. Setayesh-Mehr, and A. Asoodeh, Int. J. Pept. Res. Ther., 25, 1343 – 1341 (2019).

    Article  Google Scholar 

  10. Z. Setayesh-Mehr, A. Asoodeh, M. Poorsargol, Biologia, 76, 2735 – 2743 (2021).

    Article  CAS  Google Scholar 

  11. Z. Setayesh-Mehr and A. Asoodeh, Int. J. Pept. Res. Ther., 25(40), 1343 – 1341 (2019).

    Google Scholar 

  12. Z. Setayesh-Mehr and A. Asoodeh, Bioorg. Chem., 75, 30 – 37 (2017).

    Article  CAS  PubMed  Google Scholar 

  13. H. Keshavarz Alikhani, J. Zargan, A. Bidmeshkipour, et al., Mod. Med. Lab. J., 4, 28 – 35 (2021).

  14. A. L. Tornesello, A. Borrelli, L. Buonaguro, et al., Molecules, 25(12), 2850 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. C. Li, H. Liu, Y. Yang, et al., Front. Pharmacol., 13(9), 1297 (2018).

    Article  CAS  Google Scholar 

  16. M. Illescas, A. Peñas, J. Arenas, et al., Front. Cell Dev. Biol., 9, 95838 (2021).

    Google Scholar 

  17. H. M. Kuo, C. C. Tseng, N. F. Chen, et al., Mar. Drugs, 16(1), 8 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  18. S. Liu, J. J. Aweya, L. Zheng, et al., Cell. Biol. Toxicol., 38(1), 87 – 110 (2022).

    Article  CAS  PubMed  Google Scholar 

  19. M. Jo, M. H. Park, P. S. Kollipara, et al., Toxicol. Applied Pharmacol., 258(1), 72 – 81 (2012).

    Article  CAS  Google Scholar 

  20. L. Duprez, E. Wirawan, T. Vanden Berghe, et al., Microbes Infect., 11(13), 1050 – 1062 (2009).

  21. F. M. Yakes, W. Chinratanalab, C. A. Ritter, et al., Cancer Res., 62(14), 4132 – 4141 (2002).

    CAS  PubMed  Google Scholar 

  22. Y. Gu, S.-L. Liu, W.-Z. Yu, et al., Oncol. Lett., 5(2), 483 – 488 (2013).

    Article  CAS  PubMed  Google Scholar 

  23. G. Song, G. Ouyang, and S. Bao, J. Cell Mol. Med., 9(1), 59 – 71 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. N. Majewski, V. Nogueira, R. B. Robey, et al., Mol. Cell Biol., 24(2), 730 – 740 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. C. Li, H. Liu, Y. Yang, et al., Front. Pharmacol., 13(9), 1297 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biology, Faculty of Sciences, University of Zabol, Zabol, Iran

    Setayesh-Mehr Zahra & Rezavand Maryam

  2. Rayan Novin Pajoohan Pras, Shiraz University of Medical Sciences, Shiraz, Iran

    Parsaei Asghar

Authors
  1. Setayesh-Mehr Zahra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rezavand Maryam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Parsaei Asghar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Setayesh-Mehr Zahra.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zahra, SM., Maryam, R. & Asghar, P. The Role of the HL-10 Peptide in Regulating the Expression of Apoptosis-Related Genes in the HeLa Cancer Cell Line. Pharm Chem J 57, 1929–1933 (2024). https://doi.org/10.1007/s11094-024-03098-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-024-03098-x

Keywords

Search

Navigation